Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

New on Charts:

We've added Splits, Dividends, Earnings, and Earnings Estimates! Click on individual events to unveil more details.

If you prefer a cleaner view, easily disable them in Settings.

AXLA | Axcella Health Inc

Index- P/E- EPS (ttm)-19.14 Insider Own63.89% Shs Outstand2.95M Perf Week0.87%
Market Cap30.80M Forward P/E- EPS next Y-4.75 Insider Trans0.00% Shs Float1.06M Perf Month9.49%
Income-48.23M PEG- EPS next Q-1.25 Inst Own7.02% Short Float / Ratio22.72% / 0.26 Perf Quarter91.30%
Sales0.00M P/S- EPS this Y87.25% Inst Trans- Short Interest0.24M Perf Half Y-16.51%
Book/sh-0.77 P/B- EPS next Y0.00% ROA-162.77% Target Price- Perf Year-75.86%
Cash/sh3.01 P/C3.47 EPS next 5Y0.00% ROE-1370.17% 52W Range2.59 - 49.25 Perf YTD27.51%
Dividend- P/FCF- EPS past 5Y-2.50% ROI- 52W High-78.80% Beta0.93
Dividend %- Quick Ratio0.80 Sales past 5Y0.00% Gross Margin- 52W Low303.48% ATR4.57
Employees11 Current Ratio0.80 Sales Q/Q- Oper. Margin0.00% RSI (14)48.69 Volatility30.98% 49.35%
OptionableNo Debt/Eq- EPS Q/Q88.56% Profit Margin- Rel Volume0.86 Prev Close10.57
ShortableNo LT Debt/Eq- EarningsAug 03 BMO Payout- Avg Volume930.17K Price10.44
Recom- SMA20-26.22% SMA5023.06% SMA2001.86% Volume799,001 Change-1.23%
Date Action Analyst Rating Change Price Target Change
Oct-12-21Initiated Noble Capital Markets Outperform $6
Sep-22-21Downgrade Goldman Buy → Neutral $9 → $5
Jul-30-21Downgrade JP Morgan Neutral → Underweight
Jul-06-21Initiated H.C. Wainwright Buy $14
Jun-03-21Resumed Chardan Capital Markets Buy $10 → $16
Nov-18-20Initiated ROTH Capital Buy $28
Oct-27-20Initiated Chardan Capital Markets Buy $16
Sep-25-20Initiated B. Riley FBR Buy $14
Jul-31-20Initiated Piper Sandler Overweight $25
May-28-20Initiated Wedbush Outperform $28
Jun-03-19Initiated Goldman Buy $25
Sep-20-23 11:28AM
Sep-15-23 09:40AM
Sep-14-23 04:30PM
Aug-30-23 09:40AM
08:00AM Loading…
Aug-29-23 08:00AM
Aug-03-23 07:30AM
May-04-23 04:30PM
Apr-17-23 08:00AM
Apr-14-23 12:01PM
Mar-30-23 08:00AM
Feb-15-23 04:10PM
Feb-09-23 04:45PM
Jan-25-23 10:53AM
05:34AM Loading…
Jan-24-23 09:50AM
Jan-23-23 04:15PM
Dec-15-22 08:04AM
Dec-14-22 08:01PM
Dec-08-22 10:00AM
Nov-11-22 09:35AM
Nov-03-22 09:59AM
Nov-01-22 07:00AM
Oct-27-22 08:30AM
Oct-14-22 01:24PM
Oct-13-22 08:00AM
Sep-29-22 09:17AM
08:40AM Loading…
Sep-17-22 08:40AM
Sep-12-22 08:00AM
Aug-12-22 08:30AM
Aug-10-22 08:19AM
Aug-09-22 07:40AM
Aug-04-22 05:50AM
Aug-02-22 06:34AM
Jul-01-22 08:21AM
Jun-27-22 02:35PM
May-27-22 10:20AM
May-26-22 07:00AM
May-19-22 08:00AM
May-05-22 07:00AM
Apr-28-22 10:24AM
Apr-20-22 10:49AM
Apr-19-22 11:02AM
Apr-18-22 11:26AM
Apr-12-22 10:49AM
Apr-07-22 02:50PM
Apr-04-22 10:04AM
Mar-30-22 07:32AM
Mar-23-22 07:02AM
Mar-17-22 12:36PM
Mar-16-22 08:15AM
Mar-10-22 11:05AM
Mar-09-22 10:49AM
Feb-28-22 09:00AM
Feb-15-22 10:05AM
Feb-14-22 07:58AM
Feb-10-22 07:30AM
Feb-07-22 07:55AM
Jan-25-22 10:00AM
Jan-13-22 12:08PM
Jan-06-22 07:58AM
Jan-04-22 07:58AM
Dec-31-21 10:05AM
Dec-30-21 10:00AM
Dec-16-21 12:41PM
Dec-08-21 10:00AM
Dec-06-21 07:50AM
Nov-18-21 07:58AM
Nov-15-21 07:39AM
Nov-10-21 08:42AM
Nov-02-21 07:58AM
Oct-26-21 07:47PM
Oct-19-21 07:58AM
Oct-13-21 10:00AM
Oct-05-21 07:58AM
Sep-28-21 10:57AM
Sep-09-21 09:49AM
Sep-07-21 07:58AM
Sep-02-21 06:43AM
Aug-30-21 01:21PM
Aug-16-21 07:58AM
Jul-29-21 07:28AM
Jul-22-21 07:28AM
Jun-30-21 07:28AM
Jun-13-21 10:15AM
Jun-10-21 11:35AM
May-25-21 06:00AM
Axcella Health, Inc. is a biotechnology company. It engages in the research and development of treatment for diseases and improves health using endogenous metabolic modulator, or EMM, and compositions. Its product pipeline includes AXA1665, for the reduction in risk of recurrent overt hepatic encephalopathy, and AXA1125, for non-alcoholic steatohepatitis. The company was founded by Noubar B. Afeyan, Geoffrey von Maltzahn, and David A. Berry on August 27, 2008 and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Koziel MargaretChief Medical OfficerMar 01Sale0.5867939424,883Mar 03 04:17 PM
Hinshaw WilliamPresident & CEOOct 19Sale1.5616,00025,02782,012Oct 19 06:49 PM
Flagship Ventures Fund IV Gene10% OwnerOct 13Buy1.6410,383,76017,029,36614,101,638Oct 17 04:42 PM
Societe des Produits Nestle S.10% OwnerOct 13Buy1.643,658,5365,999,99911,105,438Oct 17 11:12 AM